These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [H1 antihistamines. Actions, adverse effects, administration]. Polk B Med Monatsschr Pharm; 2005 Apr; 28(4):114-6. PubMed ID: 15850248 [No Abstract] [Full Text] [Related]
6. Omalizumab (Xolair) for chronic urticaria. Med Lett Drugs Ther; 2013 May; 55(1417):43-4. PubMed ID: 23715129 [No Abstract] [Full Text] [Related]
7. An assessment of the novel antihistamine BW 825C in the treatment of chronic idiopathic urticaria. A placebo-controlled study. Gibson JR; Harvey SG; Barth JH; Moss MY; Burke CA Dermatologica; 1984; 169(4):179-83. PubMed ID: 6149965 [TBL] [Abstract][Full Text] [Related]
8. [Urticaria paradoxically aggraved by H1 antihistamines]. Catelain A; Freymond N; Queuille E; Nicolas JF Ann Dermatol Venereol; 2004 May; 131(5):451-3. PubMed ID: 15235532 [TBL] [Abstract][Full Text] [Related]
9. Antihistamines in the treatment of urticarial disorders. Shuster S Cutis; 1988 Oct; 42(4A):26-8. PubMed ID: 2903816 [TBL] [Abstract][Full Text] [Related]
10. Treatment of urticaria and angioedema: low-sedating H1-type antihistamines. Soter NA J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1084-7. PubMed ID: 1677011 [TBL] [Abstract][Full Text] [Related]
11. Oral antihistamines for allergic disorders. Drug Ther Bull; 2002 Aug; 40(8):59-62. PubMed ID: 12216338 [TBL] [Abstract][Full Text] [Related]